Regulation of Epstein-Barr virus reactivation from latency (Q38208532)

31 August 2017

title

Regulation of Epstein-Barr virus reactivation from latency (English)

1 reference

31 August 2017

0 references

Takayuki Murata

1

1 reference

31 August 2017

publication date

1 June 2014

1 reference

Microbiology and Immunology

31 August 2017

published in

1 reference

31 August 2017

volume

58

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

307-317

1 reference

Epstein-Barr virus and oncogenesis: from latent genes to tumours

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Reactivation of Epstein-Barr virus from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Replication of Epstein-Barr viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Latent and lytic Epstein-Barr virus replication strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Modes of infection and oncogenesis by the Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Lytic cycle switches of oncogenic human gammaherpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Spatiotemporally different DNA repair systems participate in Epstein-Barr virus genome maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Architecture of replication compartments formed during Epstein-Barr virus lytic replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Unconventional sequence requirement for viral late gene core promoters of murine gammaherpesvirus 68

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

bZIP proteins of human gammaherpesviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Switching of EBV cycles between latent and lytic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs d

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Enhancement of Zta-activated lytic transcription of Epstein-Barr virus by Ku80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Smubp-2 represses the Epstein-Barr virus lytic switch promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

NF-kappaB inhibits gammaherpesvirus lytic replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

LMP1 structure and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

The significance of LMP1 expression in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

DNA-damage response pathways triggered by viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Genome guardian p53 and viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1348-0421.12155

21 January 2018

Identifiers

DOI

10.1111/1348-0421.12155

1 reference

31 August 2017

1 reference